XILIO THERAPEUTICS INC
COM · CUSIP 98422T100
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.92.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2021 | 43 |
| Q1 2022 | 42 |
| Q2 2022 | 34 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2022 | 10 | 16 |
| Q2 2022 | 13 | 27 |
Biggest buyers
| Rock Springs Capital Management LP | Added | +171.8k |
| Laurion Capital Management LP | New | +142.9k |
| RENAISSANCE TECHNOLOGIES LLC | New | +75.3k |
| MILLENNIUM MANAGEMENT LLC | New | +50.0k |
| BAILARD, INC. | New | +36.6k |
| Ergoteles LLC | New | +17.5k |
| RBF Capital, LLC | New | +10.1k |
| MORGAN STANLEY | Added | +4.9k |
| CANNELL CAPITAL LLC | New | +4.5k |
| VANGUARD GROUP INC | Added | +2.8k |
Biggest sellers
| RA CAPITAL MANAGEMENT, L.P. | Reduced | -352.5k |
| NORGES BANK | Reduced | -278.1k |
| BlackRock Inc. | Reduced | -252.1k |
| Monashee Investment Management LLC | Sold out | -163.1k |
| STATE STREET CORP | Reduced | -78.2k |
| FMR LLC | Reduced | -69.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -58.1k |
| NORTHERN TRUST CORP | Reduced | -50.7k |
| Soleus Capital Management, L.P. | Reduced | -23.8k |
| Bank of New York Mellon Corp | Sold out | -21.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| GILEAD SCIENCES, INC. 13G · passive investor no change · filed 2026-02-12 | 19.9% |
| Coastlands Capital LP 13G · institution new · filed 2025-12-11 | 10.0% |
| Sirenia Capital Management LP 13G · institution new · filed 2026-05-15 | 9.9% |
| AbbVie Inc. 13G · passive investor new · filed 2025-02-18 | 9.0% |
| Bain Capital Life Sciences Fund II, L.P. 13G · passive investor filed 2026-02-17 | 8.5% |
| STEMPOINT CAPITAL LP 13G · institution +1.2 pts · filed 2026-02-17 | 8.4% |
| Frazier Life Sciences Public Fund, L.P. 13G · passive investor -3.2 pts · filed 2026-02-13 | 6.7% |
Fell to 5% or below in the last year: Point72 Asset Management, L.P. (0.0%, 2026-05-15)
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC 0.96% of their portfolio | 2.8m $8.2m | Unchanged |
| Atlas Venture Life Science Advisors, LLC 1.35% of their portfolio | 2.8m $8.1m | Unchanged |
| FMR LLC 0.00% of their portfolio | 2.5m $7.4m | Reduced -69.4k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.13% of their portfolio | 2.1m $6.1m | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. 0.13% of their portfolio | 1.6m $4.8m | Reduced -352.5k |
| RiverVest Venture Management LLC 6.19% of their portfolio | 1.4m $4.2m | Unchanged |
| Rock Springs Capital Management LP 0.12% of their portfolio | 1.4m $4.0m | Added +171.8k |
| AJU IB Investment Co., Ltd. 3.78% of their portfolio | 667.7k $1.9m | Unchanged |
| Soleus Capital Management, L.P. 0.21% of their portfolio | 453.7k $1.3m | Reduced -23.8k |
| Artal Group S.A. 0.07% of their portfolio | 450.0k $1.3m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 419.2k $1.2m | Added +2.8k |
| HARVARD MANAGEMENT CO INC 0.14% of their portfolio | 416.1k $1.2m | Unchanged |
| FIL Ltd 0.00% of their portfolio | 218.7k $639.0k | Unchanged |
| Laurion Capital Management LP 0.02% of their portfolio | 142.9k $417.0k | New |
| NORGES BANK 0.00% of their portfolio | 121.9k $355.9k | Reduced -278.1k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 83.6k $244.0k | Reduced -58.1k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 75.3k $220.0k | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 50.0k $146.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 47.7k $139.0k | Reduced -252.1k |
| BAILARD, INC. 0.00% of their portfolio | 36.6k $107.0k | New |
| Ergoteles LLC 0.00% of their portfolio | 17.5k $51.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 15.7k $46.0k | Reduced -78.2k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 12.9k $38.0k | Reduced -50.7k |
| RBF Capital, LLC 0.00% of their portfolio | 10.1k $29.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 7.0k $20.0k | Added +4.9k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 6.2k $18.0k | Added +1.9k |
| CANNELL CAPITAL LLC 0.00% of their portfolio | 4.5k $13.0k | New |
| UBS Group AG 0.00% of their portfolio | 2.8k $9.0k | Added +1.9k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 2.7k $8.0k | Reduced -2.1k |
| CITIGROUP INC 0.00% of their portfolio | 67 $0 | Reduced -256 |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 64 $0 | Reduced -5.6k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 51 $0 | Reduced -1.6k |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 4 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |